Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
220
DIFLUPREDNATE
(2008)
Small molecule
Glucocorticoid receptor agonist
OPHTHALMIC
Approved
Inflammation; Uveitis, Anterior
DIFLUPREDNATE
×
Maximum Phase:
4
First Approval:
2008
UNII:
S8A06QG2QE
Molecule Type:
Small molecule
Molecular Formula:
C27H34F2O7
Molecular Weight:
508.56
AlogP:
3.52
PSA:
106.97
HBD:
1.0
HBA:
#RotB:
6.0
Source:
FOSAPREPITANT DIMEGLUMINE
(2008)
Small molecule
Neurokinin 1 receptor antagonist
INJECTION; INTRAVENOUS; UNKNOWN
Approved
Neoplasms; Postoperative Nausea and Vomiting
FOSAPREPITANT DIMEGLUMINE
×
Maximum Phase:
4
First Approval:
2008
UNII:
D35FM8T64X
Molecule Type:
Small molecule
Molecular Formula:
C37H56F7N6O16P
Molecular Weight:
1004.84
AlogP:
4.37
PSA:
129.91
HBD:
3.0
HBA:
#RotB:
7.0
Source:
FOSAPREPITANT
(2008)
Small molecule
Unknown
Unknown
Approved
Unknown
FOSAPREPITANT
×
Maximum Phase:
4
First Approval:
2008
UNII:
6L8OF9XRDC
Molecule Type:
Small molecule
Molecular Formula:
C23H22F7N4O6P
Molecular Weight:
614.41
AlogP:
4.37
PSA:
129.91
HBD:
3.0
HBA:
#RotB:
7.0
Source:
FOSPROPOFOL
(2008)
Small molecule
Unknown
Unknown
Approved
Unknown
FOSPROPOFOL
×
Maximum Phase:
4
First Approval:
2008
UNII:
LZ257RZP7K
Molecule Type:
Small molecule
Molecular Formula:
C13H21O5P
Molecular Weight:
288.28
AlogP:
3.38
PSA:
75.99
HBD:
2.0
HBA:
#RotB:
6.0
Source:
PRASUGREL
(2009)
Small molecule
Unknown
Unknown
Approved
Thrombosis
PRASUGREL
×
Maximum Phase:
4
First Approval:
2009
UNII:
34K66TBT99
Molecule Type:
Small molecule
Molecular Formula:
C20H20FNO3S
Molecular Weight:
373.45
AlogP:
3.89
PSA:
46.61
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ARTEMETHER
(2009)
Small molecule
Ferriprotoporphyrin IX inhibitor
Unknown
Approved
Malaria
ARTEMETHER
×
Maximum Phase:
4
First Approval:
2009
UNII:
C7D6T3H22J
Molecule Type:
Small molecule
Molecular Formula:
C16H26O5
Molecular Weight:
298.38
AlogP:
2.84
PSA:
46.15
HBD:
0.0
HBA:
#RotB:
1.0
Source:
ESLICARBAZEPINE ACETATE
(2009)
Small molecule
Sodium channel alpha subunit blocker
ORAL
Approved
Epilepsy; Seizures
ESLICARBAZEPINE ACETATE
×
Maximum Phase:
4
First Approval:
2009
UNII:
BEA68ZVB2K
Molecule Type:
Small molecule
Molecular Formula:
C17H16N2O3
Molecular Weight:
296.33
AlogP:
3.06
PSA:
72.63
HBD:
1.0
HBA:
#RotB:
1.0
Source:
PRASUGREL HYDROCHLORIDE
(2009)
Small molecule
Purinergic receptor P2Y12 antagonist
ORAL
Approved
Acute Coronary Syndrome; Hemorrhage; Myocardial Infarction
PRASUGREL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2009
UNII:
G89JQ59I13
Molecule Type:
Small molecule
Molecular Formula:
C20H21ClFNO3S
Molecular Weight:
409.91
AlogP:
3.89
PSA:
46.61
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ESTRADIOL VALERATE
(2010)
Small molecule
Estrogen receptor alpha agonist
INJECTION
Approved
Atrophy; Hypogonadism; Menopause; Menorrhagia; Primary Ovarian Insufficiency
ESTRADIOL VALERATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
OKG364O896
Molecule Type:
Small molecule
Molecular Formula:
C23H32O3
Molecular Weight:
356.51
AlogP:
5.35
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
4.0
Source:
FINGOLIMOD HYDROCHLORIDE
(2010)
Small molecule
Sphingosine 1-phosphate receptor agonist
ORAL
Approved
Multiple Sclerosis
FINGOLIMOD HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2010
UNII:
G926EC510T
Molecule Type:
Small molecule
Molecular Formula:
C19H34ClNO2
Molecular Weight:
343.94
AlogP:
3.2
PSA:
66.48
HBD:
3.0
HBA:
#RotB:
12.0
Source:
CEFTAROLINE FOSAMIL
(2010)
Small molecule
Unknown
INTRAVENOUS
Approved
Bacterial Infections
CEFTAROLINE FOSAMIL
×
Maximum Phase:
4
First Approval:
2010
UNII:
7P6FQA5D21
Molecule Type:
Small molecule
Molecular Formula:
C22H21N8O8PS4
Molecular Weight:
684.7
AlogP:
-0.11
PSA:
223.24
HBD:
4.0
HBA:
#RotB:
11.0
Source:
FINGOLIMOD
(2010)
Small molecule
Unknown
ORAL
Approved
Immune System Diseases
FINGOLIMOD
×
Maximum Phase:
4
First Approval:
2010
UNII:
3QN8BYN5QF
Molecule Type:
Small molecule
Molecular Formula:
C19H33NO2
Molecular Weight:
307.48
AlogP:
3.2
PSA:
66.48
HBD:
3.0
HBA:
#RotB:
12.0
Source:
DABIGATRAN ETEXILATE
(2010)
Small molecule
Unknown
ORAL
Approved
Thrombosis
DABIGATRAN ETEXILATE
×
Maximum Phase:
4
First Approval:
2010
UNII:
2E18WX195X
Molecule Type:
Small molecule
Molecular Formula:
C34H41N7O5
Molecular Weight:
627.75
AlogP:
5.6
PSA:
154.03
HBD:
2.0
HBA:
#RotB:
15.0
Source:
GABAPENTIN ENACARBIL
(2011)
Small molecule
Voltage-gated calcium channel modulator
ORAL
Approved
Epilepsy; Neuralgia, Postherpetic; Restless Legs Syndrome
GABAPENTIN ENACARBIL
×
Maximum Phase:
4
First Approval:
2011
UNII:
75OCL1SPBQ
Molecule Type:
Small molecule
Molecular Formula:
C16H27NO6
Molecular Weight:
329.39
AlogP:
2.68
PSA:
101.93
HBD:
2.0
HBA:
#RotB:
7.0
Source:
AZILSARTAN KAMEDOXOMIL
(2011)
Small molecule
Type-1 angiotensin II receptor antagonist
ORAL
Approved
Hypertension; Stroke
AZILSARTAN KAMEDOXOMIL
×
Maximum Phase:
4
First Approval:
2011
UNII:
WEC6I2K1FC
Molecule Type:
Small molecule
Molecular Formula:
C30H23KN4O8
Molecular Weight:
606.63
AlogP:
4.71
PSA:
155.59
HBD:
1.0
HBA:
#RotB:
9.0
Source:
AZILSARTAN MEDOXOMIL
(2011)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
AZILSARTAN MEDOXOMIL
×
Maximum Phase:
4
First Approval:
2011
UNII:
LL0G25K7I2
Molecule Type:
Small molecule
Molecular Formula:
C30H24N4O8
Molecular Weight:
568.54
AlogP:
4.71
PSA:
155.59
HBD:
1.0
HBA:
#RotB:
9.0
Source:
ABIRATERONE ACETATE
(2011)
Small molecule
Cytochrome P450 17A1 inhibitor
ORAL
Approved
Neoplasms; Prostatic Neoplasms
ABIRATERONE ACETATE
×
Maximum Phase:
4
First Approval:
2011
UNII:
EM5OCB9YJ6
Molecule Type:
Small molecule
Molecular Formula:
C26H33NO2
Molecular Weight:
391.56
AlogP:
5.97
PSA:
39.19
HBD:
0.0
HBA:
#RotB:
2.0
Source:
TAFLUPROST
(2012)
Small molecule
Prostanoid FP receptor agonist
OPHTHALMIC
Approved
Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
TAFLUPROST
×
Maximum Phase:
4
First Approval:
2012
UNII:
1O6WQ6T7G3
Molecule Type:
Small molecule
Molecular Formula:
C25H34F2O5
Molecular Weight:
452.54
AlogP:
4.68
PSA:
75.99
HBD:
2.0
HBA:
#RotB:
12.0
Source:
GLYCEROL PHENYLBUTYRATE
(2013)
Small molecule
Glutamine sequestering agent
ORAL
Approved
Urea Cycle Disorders, Inborn
GLYCEROL PHENYLBUTYRATE
×
Maximum Phase:
4
First Approval:
2013
UNII:
ZH6F1VCV7B
Molecule Type:
Small molecule
Molecular Formula:
C33H38O6
Molecular Weight:
530.66
AlogP:
6.05
PSA:
78.9
HBD:
0.0
HBA:
#RotB:
17.0
Source:
ESOMEPRAZOLE STRONTIUM
(2013)
Small molecule
Potassium-transporting ATPase inhibitor
ORAL
Approved
Duodenal Ulcer; Gastroesophageal Reflux; Stomach Ulcer; Zollinger-Ellison Syndrome
ESOMEPRAZOLE STRONTIUM
×
Maximum Phase:
4
First Approval:
2013
UNII:
C5N25H3803
Molecule Type:
Small molecule
Molecular Formula:
C34H44N6O10S2Sr
Molecular Weight:
848.51
AlogP:
2.9
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TESTOSTERONE UNDECANOATE
(2014)
Small molecule
Androgen Receptor agonist
INTRAMUSCULAR; ORAL
Approved
Hypogonadism; Klinefelter Syndrome; Neoplasms; Orchitis
TESTOSTERONE UNDECANOATE
×
Maximum Phase:
4
First Approval:
2014
UNII:
H16A5VCT9C
Molecule Type:
Small molecule
Molecular Formula:
C30H48O3
Molecular Weight:
456.71
AlogP:
7.96
PSA:
43.37
HBD:
0.0
HBA:
#RotB:
10.0
Source:
PERINDOPRIL ARGININE
(2015)
Small molecule
Angiotensin-converting enzyme inhibitor
Unknown
Approved
Coronary Artery Disease; Hypertension; Myocardial Infarction
PERINDOPRIL ARGININE
×
Maximum Phase:
4
First Approval:
2015
UNII:
TFT5IM1KGB
Molecule Type:
Small molecule
Molecular Formula:
C25H46N6O7
Molecular Weight:
542.68
AlogP:
1.94
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
8.0
Source:
TENOFOVIR ALAFENAMIDE FUMARATE
(2015)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ORAL
Approved
HIV Infections; Hepatitis B, Chronic
TENOFOVIR ALAFENAMIDE FUMARATE
×
Maximum Phase:
4
First Approval:
2015
UNII:
FWF6Q91TZO
Molecule Type:
Small molecule
Molecular Formula:
C46H62N12O14P2
Molecular Weight:
1069.02
AlogP:
2.97
PSA:
143.48
HBD:
2.0
HBA:
#RotB:
11.0
Source:
TENOFOVIR ALAFENAMIDE
(2015)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
Unknown
Approved
Virus Diseases
TENOFOVIR ALAFENAMIDE
×
Maximum Phase:
4
First Approval:
2015
UNII:
EL9943AG5J
Molecule Type:
Small molecule
Molecular Formula:
C21H29N6O5P
Molecular Weight:
476.47
AlogP:
2.97
PSA:
143.48
HBD:
2.0
HBA:
#RotB:
11.0
Source:
ARIPIPRAZOLE LAUROXIL
(2015)
Small molecule
Dopamine D2 receptor partial agonist
INTRAMUSCULAR
Approved
Autistic Disorder; Bipolar Disorder; Depressive Disorder, Major; Schizophrenia; Tourette Syndrome
ARIPIPRAZOLE LAUROXIL
×
Maximum Phase:
4
First Approval:
2015
UNII:
B786J7A343
Molecule Type:
Small molecule
Molecular Formula:
C36H51Cl2N3O4
Molecular Weight:
660.73
AlogP:
8.68
PSA:
62.32
HBD:
0.0
HBA:
#RotB:
19.0
Source:
IXAZOMIB CITRATE
(2015)
Small molecule
26S proteosome inhibitor
ORAL
Approved
Multiple Myeloma; Neoplasms
IXAZOMIB CITRATE
×
Maximum Phase:
4
First Approval:
2015
UNII:
46CWK97Z3K
Molecule Type:
Small molecule
Molecular Formula:
C20H23BCl2N2O9
Molecular Weight:
517.13
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DEFLAZACORT
(2017)
Small molecule
Glucocorticoid receptor agonist
ORAL
Approved
Muscular Dystrophies; Muscular Dystrophy, Duchenne
DEFLAZACORT
×
Maximum Phase:
4
First Approval:
2017
UNII:
KR5YZ6AE4B
Molecule Type:
Small molecule
Molecular Formula:
C25H31NO6
Molecular Weight:
441.52
AlogP:
2.56
PSA:
102.26
HBD:
1.0
HBA:
#RotB:
3.0
Source:
TELOTRISTAT ETHYL
(2017)
Small molecule
Tryptophan 5-hydroxylase inhibitor
Unknown
Approved
Unknown
TELOTRISTAT ETHYL
×
Maximum Phase:
4
First Approval:
2017
UNII:
8G388563M7
Molecule Type:
Small molecule
Molecular Formula:
C27H26ClF3N6O3
Molecular Weight:
574.99
AlogP:
4.99
PSA:
131.17
HBD:
2.0
HBA:
#RotB:
9.0
Source:
BALOXAVIR MARBOXIL
(2018)
Small molecule
Polymerase acidic protein inhibitor
ORAL
Approved
Influenza, Human; Virus Diseases
BALOXAVIR MARBOXIL
×
Maximum Phase:
4
First Approval:
2018
UNII:
505CXM6OHG
Molecule Type:
Small molecule
Molecular Formula:
C27H23F2N3O7S
Molecular Weight:
571.56
AlogP:
3.39
PSA:
99.54
HBD:
0.0
HBA:
#RotB:
4.0
Source:
FOSNETUPITANT
(2018)
Small molecule
Unknown
Unknown
Approved
Unknown
FOSNETUPITANT
×
Maximum Phase:
4
First Approval:
2018
UNII:
T672P80L2S
Molecule Type:
Small molecule
Molecular Formula:
C31H35F6N4O5P
Molecular Weight:
688.61
AlogP:
5.74
PSA:
106.03
HBD:
1.0
HBA:
#RotB:
8.0
Source:
FOSTAMATINIB
(2018)
Small molecule
Tyrosine-protein kinase SYK inhibitor
Unknown
Approved
Hemorrhage
FOSTAMATINIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
SQ8A3S5101
Molecule Type:
Small molecule
Molecular Formula:
C23H26FN6O9P
Molecular Weight:
580.47
AlogP:
3.09
PSA:
186.72
HBD:
4.0
HBA:
#RotB:
10.0
Source:
FOSTAMATINIB DISODIUM
(2018)
Small molecule
Tyrosine-protein kinase SYK inhibitor
ORAL
Approved
Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia
FOSTAMATINIB DISODIUM
×
Maximum Phase:
4
First Approval:
2018
UNII:
86EEZ49YVB
Molecule Type:
Small molecule
Molecular Formula:
C23H36FN6Na2O15P
Molecular Weight:
732.52
AlogP:
3.09
PSA:
186.72
HBD:
4.0
HBA:
#RotB:
10.0
Source:
REMDESIVIR
(2020)
Small molecule
RNA-directed RNA polymerase L inhibitor
Unknown
Approved
Severe Acute Respiratory Syndrome; Virus Diseases
REMDESIVIR
×
Maximum Phase:
4
First Approval:
2020
UNII:
3QKI37EEHE
Molecule Type:
Small molecule
Molecular Formula:
C27H35N6O8P
Molecular Weight:
602.59
AlogP:
2.31
PSA:
203.55
HBD:
4.0
HBA:
#RotB:
13.0
Source:
ARTESUNATE
(2020)
Small molecule
Unknown
Unknown
Approved
Malaria
ARTESUNATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
60W3249T9M
Molecule Type:
Small molecule
Molecular Formula:
C19H28O8
Molecular Weight:
384.43
AlogP:
2.6
PSA:
100.52
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GALIDESIVIR
(1)
Small molecule
Genome polyprotein inhibitor
Unknown
Investigational
Unknown
GALIDESIVIR
×
Maximum Phase:
1
First Approval:
None
UNII:
OLF97F86A7
Molecule Type:
Small molecule
Molecular Formula:
C11H15N5O3
Molecular Weight:
265.27
AlogP:
-1.73
PSA:
140.31
HBD:
6.0
HBA:
#RotB:
2.0
Source:
AV-101
(2)
Small molecule
Glutamate [NMDA] receptor antagonist
Unknown
Investigational
Unknown
AV-101
×
Maximum Phase:
2
First Approval:
None
UNII:
77XLH9L40B
Molecule Type:
Small molecule
Molecular Formula:
C10H11ClN2O3
Molecular Weight:
242.66
AlogP:
0.91
PSA:
106.41
HBD:
3.0
HBA:
#RotB:
4.0
Source:
1
2
…
4
5
6
7
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA